CEO of sports shoe and apparel maker acknowledges need for a ‘reset’ in the country as it also navigates Trump tariffs ...

Cassava Sciences said the FDA had placed a hold on its trial for a drug to treat epilepsy. Shares slid 13% to $2.49 after the bell. KB Home delivered fewer homes and recorded a lower profit in its ...

Nike made some progress with its turnaround plan in the fiscal second quarter, but expects to return to a sales decline in the current quarter, as weakness in China continues. Executives at the ...

Nike Inc. reported fiscal second-quarter results that beat Wall Street’s expectations, but its margins shrank, and management ...

Nike made some progress with its turnaround plan in the fiscal second quarter, but expects to return to a sales decline in ...

Nike reported second-quarter financial results for fiscal 2026. The company surpassed analysts' top- and bottom-line ...

By co-founding the player-owned league Unrivalled, basketball players Breanna Stewart and Napheesa Collier transformed the ...

NIKE posted better-than-expected sales in the latest quarter, showing progress in its turnaround efforts, but weakness persisted in China and the Converse brand. Read more at The Business Times.